z-logo
Premium
The prognostic ability of early Braden Q Scores in critically ill children
Author(s) -
Tume Lyvonne N,
Siner Sarah,
Scott Elaine,
Lane Steven
Publication year - 2014
Publication title -
nursing in critical care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.689
H-Index - 43
eISSN - 1478-5153
pISSN - 1362-1017
DOI - 10.1111/nicc.12035
Subject(s) - medicine , intensive care unit , critically ill , pediatric intensive care unit , predictive value , confidence interval , cohort , intensive care , pediatrics , population , retrospective cohort study , cohort study , emergency medicine , intensive care medicine , environmental health
Background Pressure ulcer ( PU ) risk assessment tools are an important component of good nursing care; however, it is essential that these tools offer a good sensitivity and specificity, in addition to clinical utility in the population being assessed. Objectives The aim of this study was to examine how the lowest Braden Q score recorded in the first 24 h of paediatric intensive care unit admission related to the risk of PU development in an English PICU (paediatric intensive care unit). Methods A retrospective cohort study was undertaken over 12 months in a single PICU in the North West of England. 891 critically ill children with a Braden Q score were evaluated. The lowest Braden Q score within the first 24 h of PICU admission was matched to reported PU development and grade. Results The Braden Q score was found to perform well in children aged 3 weeks to 8 years without congenital heart disease ( CHD ), which is the population it was validated on. At a cut off score of ≤16 it yielded a sensitivity of 100% specificity of 73.1%, positive predictive value ( PPV ) 2.56 and a negative predictive value ( NPV ) of 100 and an area under the curve ( AUC ) of 0.87(0.75–0.98). When used in other age groups and when it included children with CHD , it performed less well with lower AUC and wider confidence intervals, but it performed moderately well in the group of term to 14 years with a sensitivity of 75% specificity of 72.6%, PPV 1.5 and a NPV of 99.8 and AUC of 0.74 (0.49–0.98). Conclusion Our results in a heterogeneous UK PICU population found the Braden Q score performed well in the specific population it was validated for ( PICU children aged 3 weeks to 8 years without CHD), however, it performed moderately well in the more heterogonous PICU population of term to 14 years including children with CHD .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom